• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Use of prescription drugs affecting fracture risk not changed after fracture

byJames EnglandandAnees Daud
August 24, 2016
in Chronic Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a retrospective cohort study of Medicare beneficiaries, there was no overall change in prescribing patterns of drugs that increased or decreased fracture risk before and after fragility fractures.

2. There was a subset of patients for whom the prescribing of high risk medications decreased, but this was matched by new prescriptions of these medications for other patients.

Evidence Rating Level: 2 (Good)      

Study Rundown: For an aging population, fragility fractures are common and are associated with significant morbidity and mortality. While risk of fragility fractures is affected my many non-modifiable factors such as age, gender, and genetics, decreasing the use of medications associated with fragility fractures presents an opportunity to improve care. Medications that can increase risk of fragility fractures include those associated with increased falls (sedatives, hypnotics, opioids, antihypertensives), decreased bone density (glucocorticoids, PPIs, anticonvulsants), or through unknown mechanisms (antipsychotics). Medications that help reduce the risk of fractures include bisphosphonates.

This study evaluated the use of prescription medications that increased or decreased risk of fractures to evaluate changes in prescribing patterns following incident fractures. The results showed that use of studied medications did not change significantly following fragility fractures. There was a subset of patients for whom the use of implicated medications decreased, however this was matched by new prescriptions for other patients. Additionally, there was not a clinically significant increase in the use of bisphosphonates following the fragility fracture. This study highlighted the importance for in-depth review of medications following major medical events such as fragility fractures. The weakness of the study included not evaluating the overall outcomes after the incident fracture. Also, the study did not explore the indication for the medications used.

Click to read the study, published today in JAMA Internal Medicine

Relevant Reading: Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care

RELATED REPORTS

COVID-19-related hospital policies not associated with delays in urgent open and closed fracture surgeries compared to pre-pandemic

Postoperative infection post-fracture linked to substantially reduced future household income

Proton pump inhibitor use in pediatric patients may increase fracture risk

In-Depth [retrospective cohort]: This study evaluated 168 133 patients with a fragility fracture (hip, shoulder, or wrist), from 2007 to 2011. Patients were Medicare beneficiaries enrolled for at least 4 months who resided in the community (rather than skilled nursing facility), and were excluded if they were enrolled in hospice, nursing home, or did not fill any prescriptions during the study periods. A total of 21 drug classes were investigated due to prior studies linking them to increased risk of fragility fractures. These included: benzodiazepines, barbiturates, opioids, hypnotics, SSRIs, antihypertensives, diuretics, glucocorticoids, PPIs, antipsychotics and others.

Prior to the index fracture, 76% of patients were on at least one study medication in the preceding 4 months. Following the fracture, the proportion of patients on at least 1 non-opioid implicated medication was 80.5% for hip fractures, 74.3% for wrist, and 76.9% for shoulder. There was a group of patients with reduced use of medications implicated in fracture risk, but this was matched with a group of patients that began new medications with fracture risk. The use of drugs that increase bone density did rise following fragility fractures significantly (p < 0.001), however the absolute number was very small (21.1% vs. 22.7%), and so not clinically significant.

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: fracture
Previous Post

Rates of intussusception increase with rotavirus vaccine

Next Post

Team-based care systems compare favorably with traditional practice models

RelatedReports

Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery
Infectious Disease

COVID-19-related hospital policies not associated with delays in urgent open and closed fracture surgeries compared to pre-pandemic

November 2, 2021
Quick Take: Effect of intranasal ketamine vs. fentanyl on pain reduction for extremity injuries in children: the PRIME randomized clinical trial
2 Minute Medicine

Postoperative infection post-fracture linked to substantially reduced future household income

June 2, 2021
Proton pump inhibitor use in pediatric patients may increase fracture risk
Gastroenterology

Proton pump inhibitor use in pediatric patients may increase fracture risk

April 3, 2020
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial
Chronic Disease

Odanacatib for the treatment of postmenopausal osteoporosis

November 14, 2019
Next Post
HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital

Team-based care systems compare favorably with traditional practice models

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

70-gene signature test may accurately determine prognosis in early stage breast cancer

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Inotuzumab ozogamicin linked to better outcomes than standard chemotherapy for ALL: The INO-VATE ALL trial

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.